These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9063912)

  • 21. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged psychotic relapse after abrupt clozapine withdrawal.
    Parsa MA; al-Lahham YH; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1993 Apr; 13(2):154-5. PubMed ID: 8463447
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
    Poyurovsky M; Bergman Y; Shoshani D; Schneidman M; Weizman A
    Clin Neuropharmacol; 1998; 21(2):97-100. PubMed ID: 9579295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
    Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
    Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
    [No Abstract]   [Full Text] [Related]  

  • 26. Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing.
    Borison RL
    Clin Ther; 1996; 18(4):592-607; discussion 591. PubMed ID: 8879889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.
    Tanríverdi N; Yazící KM
    Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523
    [No Abstract]   [Full Text] [Related]  

  • 29. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review.
    Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T
    East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 108(1-2):67-71. PubMed ID: 1410148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
    Wetter TC; Lauer CJ; Gillich G; Pollmächer T
    J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral stimulation associated with risperidone initiation.
    Byerly MJ; Greer RA; Evans DL
    Am J Psychiatry; 1995 Jul; 152(7):1096-7. PubMed ID: 7540799
    [No Abstract]   [Full Text] [Related]  

  • 36. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
    Weiss EL; Longhurst JG; Bowers MB; Mazure CM
    J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of clozapine on sleep: a longitudinal study.
    Hinze-Selch D; Mullington J; Orth A; Lauer CJ; Pollmächer T
    Biol Psychiatry; 1997 Aug; 42(4):260-6. PubMed ID: 9270902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 40. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal.
    Ekblom B; Eriksson K; Lindström LH
    Psychopharmacology (Berl); 1984; 83(3):293-4. PubMed ID: 6433395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.